Evidence map›Paper›PMID 40801817›Full record

SynthesisDeutsches Arzteblatt international2025

Mortality After Osteoporotic Vertebral Body Fractures: Cement Augmentation Versus Conservative Treatment—A Systematic Review and Meta-Analysis.

Andreas Wiedl, Florian Geiger, Johanna Eberl, André Wirries, Ahmed Hammad

Abstract readComparative StudyMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Deutsches Arzteblatt international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andreas WiedlHessing Foundation, Orthopedic Clinics, Spine Center, Augsburg; Orthopedic & Traumatology Hospital, Spinal Surgery, Kantonsspital Baselland, Bruderholz, Switzerland.
Florian Geiger
Johanna Eberl
André Wirries
Ahmed Hammad

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteoporotic vertebral body fractures are associated with a 1-year mortality of 28%, a figure similar to that for hip fractures. Retrospective registry studies from multiple countries have shown a survival advantage in patients treated with an augmentation procedure.

methodsWe carried out a systematic review of publications retrieved from the PubMed, Livivo, Cochrane Central, and Web of Science databases, and from the internet at large via Google Scholar. Studies were selected for analysis if they included a comparison of mortality in patients with osteoporotic vertebral body fractures who were treated conservatively versus those who were treated with cement augmentation. We also carried out a pooled quantitative analysis based on the findings of all studies in which a hazard ratio (HR) comparing the two modes of treatment was reported.

results22 publications met the inclusion criteria, including two randomized, controlled trials (RCTs). The two RCTs and 8 of the remaining studies showed no significant difference in mortality between the two groups; a significant positive effect of augmentation was reported in a further 11 studies, and a significant negative effect in 1. 11 studies were suitable for inclusion in the quantitative analysis. The pooled HR for death was 0.91 (95% confidence interval [0.73; 1.15]; p = 0.39), i.e., mildly in favor of augmentation, but statistically insignificant.

conclusionA wide variety of confounders may have led to an overestimation, in retrospective studies, of the survival advantage putatively conferred by cement augmentation of vertebral body fractures compared to conservative treatment. Our systematic review and meta-analysis revealed no significant association of either form of treatment with a higher survival rate.

Indexed as

Bone CementsConservative TreatmentOsteoporotic FracturesSpinal FracturesVertebroplastyAgedAged, 80 and overComorbidityFemaleHumansMaleMiddle AgedRisk FactorsSurvival RateTreatment OutcomeBone Cements

Identifiers

PMID40801817
PMCPMC12693679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.